Alembic Pharma surges 10% on strong Q4 results; stock zooms 56% in a month

Last week, the stock hit a fresh 52-week high of Rs 706 on the BSE

Shares of Alembic Pharmaceuticals surged 10 per cent to Rs 699 on the BSE on Thursday after the company's consolidated profit before tax (PBT) more than doubled at Rs 298 crore in the January-March quarter (Q4FY20), on the back of healthy revenue. The drug maker had a PBT of Rs 139 crore during the same quarter in previous fiscal.

Total revenue of the company during the quarter under review grew 30 per cent year-on-year (YoY) at Rs 1,207 crore against Rs 927 crore in the corresponding quarter of previous year.

The company’s international formulations business grew 80 per